Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion

Anett Dunai, Réka Spohn, Zoltán Farkas, Viktória Lázár, Ádám Györkei, Gábor Apjok, Gábor Boross, Balázs Szappanos, Gábor Grézal, Anikó Faragó, L. Bodai, B. Papp, C. Pál

Research output: Contribution to journalArticle

Abstract

Antibiotic resistance typically induces a fitness cost that shapes the fate of antibiotic-resistant bacterial populations. However, the cost of resistance can be mitigated by compensatory mutations elsewhere in the genome, and therefore the loss of resistance may proceed too slowly to be of practical importance. We present our study on the efficacy and phenotypic impact of compensatory evolution in Escherichia coli strains carrying multiple resistance mutations. We have demonstrated that drug-resistance frequently declines within 480 generations during exposure to an antibiotic-free environment. The extent of resistance loss was found to be generally antibiotic-specific, driven by mutations that reduce both resistance level and fitness costs of antibiotic-resistance mutations. We conclude that phenotypic reversion to the antibiotic-sensitive state can be mediated by the acquisition of additional mutations, while maintaining the original resistance mutations. Our study indicates that restricting antimicrobial usage could be a useful policy, but for certain antibiotics only.

Original languageEnglish
JournaleLife
Volume8
DOIs
Publication statusPublished - Aug 16 2019

Fingerprint

Bacterial Drug Resistance
Microbial Drug Resistance
Escherichia coli
Anti-Bacterial Agents
Mutation
Pharmaceutical Preparations
Costs and Cost Analysis
Costs
Drug Resistance
Genome
Genes
Population

Keywords

  • antibiotic resistance
  • compensatory mutations
  • E. coli
  • evolution
  • evolutionary biology

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion. / Dunai, Anett; Spohn, Réka; Farkas, Zoltán; Lázár, Viktória; Györkei, Ádám; Apjok, Gábor; Boross, Gábor; Szappanos, Balázs; Grézal, Gábor; Faragó, Anikó; Bodai, L.; Papp, B.; Pál, C.

In: eLife, Vol. 8, 16.08.2019.

Research output: Contribution to journalArticle

Dunai, A, Spohn, R, Farkas, Z, Lázár, V, Györkei, Á, Apjok, G, Boross, G, Szappanos, B, Grézal, G, Faragó, A, Bodai, L, Papp, B & Pál, C 2019, 'Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion', eLife, vol. 8. https://doi.org/10.7554/eLife.47088
Dunai, Anett ; Spohn, Réka ; Farkas, Zoltán ; Lázár, Viktória ; Györkei, Ádám ; Apjok, Gábor ; Boross, Gábor ; Szappanos, Balázs ; Grézal, Gábor ; Faragó, Anikó ; Bodai, L. ; Papp, B. ; Pál, C. / Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion. In: eLife. 2019 ; Vol. 8.
@article{91a41a9edaca4bf48150303eea9f0257,
title = "Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion",
abstract = "Antibiotic resistance typically induces a fitness cost that shapes the fate of antibiotic-resistant bacterial populations. However, the cost of resistance can be mitigated by compensatory mutations elsewhere in the genome, and therefore the loss of resistance may proceed too slowly to be of practical importance. We present our study on the efficacy and phenotypic impact of compensatory evolution in Escherichia coli strains carrying multiple resistance mutations. We have demonstrated that drug-resistance frequently declines within 480 generations during exposure to an antibiotic-free environment. The extent of resistance loss was found to be generally antibiotic-specific, driven by mutations that reduce both resistance level and fitness costs of antibiotic-resistance mutations. We conclude that phenotypic reversion to the antibiotic-sensitive state can be mediated by the acquisition of additional mutations, while maintaining the original resistance mutations. Our study indicates that restricting antimicrobial usage could be a useful policy, but for certain antibiotics only.",
keywords = "antibiotic resistance, compensatory mutations, E. coli, evolution, evolutionary biology",
author = "Anett Dunai and R{\'e}ka Spohn and Zolt{\'a}n Farkas and Vikt{\'o}ria L{\'a}z{\'a}r and {\'A}d{\'a}m Gy{\"o}rkei and G{\'a}bor Apjok and G{\'a}bor Boross and Bal{\'a}zs Szappanos and G{\'a}bor Gr{\'e}zal and Anik{\'o} Farag{\'o} and L. Bodai and B. Papp and C. P{\'a}l",
year = "2019",
month = "8",
day = "16",
doi = "10.7554/eLife.47088",
language = "English",
volume = "8",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion

AU - Dunai, Anett

AU - Spohn, Réka

AU - Farkas, Zoltán

AU - Lázár, Viktória

AU - Györkei, Ádám

AU - Apjok, Gábor

AU - Boross, Gábor

AU - Szappanos, Balázs

AU - Grézal, Gábor

AU - Faragó, Anikó

AU - Bodai, L.

AU - Papp, B.

AU - Pál, C.

PY - 2019/8/16

Y1 - 2019/8/16

N2 - Antibiotic resistance typically induces a fitness cost that shapes the fate of antibiotic-resistant bacterial populations. However, the cost of resistance can be mitigated by compensatory mutations elsewhere in the genome, and therefore the loss of resistance may proceed too slowly to be of practical importance. We present our study on the efficacy and phenotypic impact of compensatory evolution in Escherichia coli strains carrying multiple resistance mutations. We have demonstrated that drug-resistance frequently declines within 480 generations during exposure to an antibiotic-free environment. The extent of resistance loss was found to be generally antibiotic-specific, driven by mutations that reduce both resistance level and fitness costs of antibiotic-resistance mutations. We conclude that phenotypic reversion to the antibiotic-sensitive state can be mediated by the acquisition of additional mutations, while maintaining the original resistance mutations. Our study indicates that restricting antimicrobial usage could be a useful policy, but for certain antibiotics only.

AB - Antibiotic resistance typically induces a fitness cost that shapes the fate of antibiotic-resistant bacterial populations. However, the cost of resistance can be mitigated by compensatory mutations elsewhere in the genome, and therefore the loss of resistance may proceed too slowly to be of practical importance. We present our study on the efficacy and phenotypic impact of compensatory evolution in Escherichia coli strains carrying multiple resistance mutations. We have demonstrated that drug-resistance frequently declines within 480 generations during exposure to an antibiotic-free environment. The extent of resistance loss was found to be generally antibiotic-specific, driven by mutations that reduce both resistance level and fitness costs of antibiotic-resistance mutations. We conclude that phenotypic reversion to the antibiotic-sensitive state can be mediated by the acquisition of additional mutations, while maintaining the original resistance mutations. Our study indicates that restricting antimicrobial usage could be a useful policy, but for certain antibiotics only.

KW - antibiotic resistance

KW - compensatory mutations

KW - E. coli

KW - evolution

KW - evolutionary biology

UR - http://www.scopus.com/inward/record.url?scp=85071715321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071715321&partnerID=8YFLogxK

U2 - 10.7554/eLife.47088

DO - 10.7554/eLife.47088

M3 - Article

VL - 8

JO - eLife

JF - eLife

SN - 2050-084X

ER -